Literature DB >> 266721

Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts.

A Kaplan, D T Achord, W S Sly.   

Abstract

Human beta-glucuronidase (beta-D-glucuronide glucuronosohydrolase, EC 3.2.1.31), like many other glycoprotein lysosomal hydrolases, is specifically taken up from the culture medium by human fibroblasts. Prior work has indicated that the enzyme exhibits charge heterogeneity and that "high-uptake" forms, i.e., those rapidly internalized by human fibroblasts, are more acidic than slowly internalized forms. Here we present two lines of evidence that the acidic group required for the high-uptake property of certain forms of the enzyme is a phosphate on, or in proximity to, a D-mannose-type carbohydrate. The first line of evidence was obtained from analysis of inhibition of enzyme pinocytosis by yeast mannans, phosphorylated sugars, and sugars. Mannans that contained phosphate were more potent inhibitors than those that did not contain phosphate. D-Mannose 6-phosphate was a more potent inhibitor than either D-mannose 1 phosphate or 2-deoxy-D-glucose 6-phosphate. D-Mannose and certain related sugars were weak pinocytosis inhibitors, while 2- and 4-epimers of mannose were noninhibitory. Competitive inhibition was demonstrated and the apparent Kis estimated for the following compounds: Saccharomyces cerevisiae mannan from mutant X2180-mnnl, 3 X 10(-6) M; mannan from wild-type S. cerebisiae, 3 X 10(-5) M; D-mannose 6-phosphate, 6 X 10(-5) M; L-fucose, 4 X 10(-2) M; and D-mannose, 6 X 10(-2) M. The second line of evidence comes from the observation that alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1] treatment of human platelet beta-glucuronidase abolished its "high-uptake" activity, without diminishing its catalytic activity, and converted some forms of the heterogeneous enzyme to less acidic forms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266721      PMCID: PMC431066          DOI: 10.1073/pnas.74.5.2026

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  A novel uridine nucleotide containing N-acetyl-glucosamine and galactose.

Authors:  S SUZUKI
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts.

Authors:  S Hickman; L J Shapiro; E F Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1974-03-15       Impact factor: 3.575

4.  A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes.

Authors:  S Hickman; E F Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1972-11-15       Impact factor: 3.575

5.  Studies on the pathogenetic mechanism of I-cell disease in cultured fibroblasts.

Authors:  U N Wiesmann; N N Herschkowitz
Journal:  Pediatr Res       Date:  1974-11       Impact factor: 3.756

6.  Polymorphism of the somatic antigen of yeast.

Authors:  C E Ballou; W C Raschke
Journal:  Science       Date:  1974-04-12       Impact factor: 47.728

7.  Uptake of beta-glucuronidase by deficient human fibroblasts.

Authors:  D Lagunoff; D M Nicol; P Pritzi
Journal:  Lab Invest       Date:  1973-10       Impact factor: 5.662

8.  The role of glycosidically bound mannose in the assimilation of beta-galactosidase by generalized gangliosidosis fibroblasts.

Authors:  V Hieber; J Distler; R Myerowitz; R D Schmickel; G W Jourdian
Journal:  Biochem Biophys Res Commun       Date:  1976-12-06       Impact factor: 3.575

9.  Effect of glycosylation on the in vivo circulating half-life of ribonuclease.

Authors:  J W Baynes; F Wold
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

10.  Glycosylation of hemoglobin in vitro: affinity labeling of hemoglobin by glucose-6-phosphate.

Authors:  D N Haney; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  165 in total

Review 1.  Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood- brain barrier.

Authors:  William S Sly; Carole Vogler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 2.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

3.  Recognition of human urine alpha-N-acetylglucosaminidase by rat hepatocytes. Involvement of receptors specific for galactose, mannose 6-phosphate and mannose.

Authors:  K Ullrich; R Basner; V Gieselmann; K Von Figura
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

Review 4.  Replacement therapy in the mucopolysaccharidoses.

Authors:  M F Dean
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

5.  Binding receptors for alpha-L-fucosidase in human B-lymphoid cell lines.

Authors:  R A Dicioccio; A L Miller
Journal:  Glycoconj J       Date:  1992-02       Impact factor: 2.916

6.  The missing link in lysosomal enzyme targeting.

Authors:  W S Sly
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 7.  New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Mar-Apr

8.  An oligosaccharide-containing factor that induces cell differentiation in Dictyostelium discoideum.

Authors:  C Town; E Stanford
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

9.  Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.

Authors:  C A Gabel; L Dubey; S P Steinberg; D Sherman; M D Gershon; A A Gershon
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome.

Authors:  Mei Dai; Jingfen Han; Salim S El-Amouri; Roscoe O Brady; Dao Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.